November 9, 2017 | Israeli clinical stage biotech company MitrAssist has raised $30 million, in a funding round led by Fosun Pharma, the pharmaceutical arm of China-based pharmaceutical company Fosun International. China’s Ping Ang Insurance Company also contributed to the round. The heart valve company received $16 million according to its pre-closing valuation of $80 […]